Psychedelics

Why do we take psychedelics during the night?

Have you ever wondered why we often take entheogens during the night?

Typically, we take entheogens to find peace of mind outside of our routines. But we can consume these compounds at any time of the day and have the same effect, or wouldn’t we?

Perhaps the connection between both is more ingrained in the exhaustion of our senses and missing our connection to nature than you may think!

Why do we take psychedelics during the night? Read More »

Zebrafish might be the future of studying neuroactive compounds

Fully understanding the mechanisms of action of neuroactive compounds is difficult due to their complexity and polypharmacology. Making single-target drug discovery nearly impossible.

Phenotypic screening was one of the solutions brought by science. However, this method faced historical limitations until recently.

A group of researchers from the University of California found a way to rapidly profile thousands of compounds using larval zebrafish, which share genetics and CNS anatomy with humans, making complex behavioral readouts possible.

Find more here!

Zebrafish might be the future of studying neuroactive compounds Read More »

Breaking Language Barriers with Francesco De Luca

As Terence McKenna and others once said: ‘Everyone can learn about entheogens from books.’

Unfortunately, sometimes, we can’t read them due to language barriers.

For this reason, we spoke to Francesco De Luca, a poet and translator of the McKenna brother’s golden literary pieces.

Join us to learn more about the importance of literature, his stance on the world as a McKennian, younger generations losing touch with literature, how the world is becoming weird, and Terence McKenna’s philosophies.

Breaking Language Barriers with Francesco De Luca Read More »

What was Aldous Huxley’s Influence on Psychedelic Culture?

Aldous Huxley is one of the many authors when we want to mention the most renowned authors.

Many people love his unique writing style and philosophy, including Alexander Shulgin, Terence McKenna, and several other scientific researchers who often mentioned his name and works.
But exactly what attracts the hallucinogen community to him?

Read more here!

What was Aldous Huxley’s Influence on Psychedelic Culture? Read More »

Psychedelia: A quest for the unknown

Recently, something has become a martyr in my head, and I think many people have this same question.

Why do people keep on using psychedelics?

Could it be that what we seek in psychedelic experiences represents the epitome of human existence as we try to satisfy our rooted curiosity about the unknown and could be the reasoning behind why people continuously explore the realms of consciousness and, consequently, psychedelics?

Psychedelia: A quest for the unknown Read More »

What is the Novel concept Entheogenic Synergy?

Following up on last week’s article, we clear up what we coined as Entheogenic Synergy, which bifurcates into Recreational Synergy and Therapeutic Synergy, concepts intended to raise awareness of anthropological values, beliefs, and elements susceptible to changing our biochemistry, microbiota, neurochemistry, and the way we think, such as music, hearing other experiences, expectations, and the journey to our destination, as well as conversations we have about the experience, being present to a new environment and language, learning to adapt, changing our neuroplasticity and thermoregulation are explored as equally as the psychedelic experience, and even further, be included in the psychedelic experience in the future research. 

What is the Novel concept Entheogenic Synergy? Read More »

Slow releasing Ketamine tablets might be the future for the treatment of severe depression

The notion of Ketamine being a horse tranquilizer is slowly shifting into the compound as a tool in psychotherapy for the treatment of several mental illnesses, allowing novel therapies, such as Ketamine VR and using Ketamine to treat post-finasteride syndrome, to be developed.

However, there is a downside to Ketamine therapy. Its availability, the cost, and the fact that patients stay in clinics for two hours after administration. But this might be changing soon!

Researchers are currently in clinical trials for the approval of a slow-releasing racemic Ketamine tablet that will lower the cost of Ketamine therapy and can be administered at home by the patient as it doesn’t have the typical dissociative side effects in IV Ketamine and has low chances of addiction according to researchers.

Slow releasing Ketamine tablets might be the future for the treatment of severe depression Read More »

One step closer to saving a species! (Bufo alvarius)

In the last five years, two words have spread like wildfire, “Toad Medicine” (5-MeO-DMT) is in the mouths of celebrities, herpetologists, psychonauts, and curious people. This curiosity narrowed Incilius Alvarius to endangerment due to poaching and increased movement on the Sonoran roads. Fortunately, researchers at Mount Sinai Hospital and Columbia University greeted us with another synthetic alternative to stop harming the toads 4-F,5-MeO-PyrT.

Could this be a queue to stop seeing this toad as a “medicine” and see it as a living species once again and stop abusing it for personal benefit?

One step closer to saving a species! (Bufo alvarius) Read More »

Shopping Cart